A 36-year-old mother took an experimental drug for morning sickness while she was pregnant. Several years later, this experimental drug is found to be a toxic agent that disturbs normal fetal development of the loop of Henle. Which of the following regulatory factors may contribute to this drug’s toxic side effect?
A. Bone morphogenic protein-5
B. Bone morphogenic protein-6
C. Bone morphogenic protein-4
D. Bone morphogenic protein-7
E. Bone morphogenic protein-3
A. Bone morphogenic protein-5
B. Bone morphogenic protein-6
C. Bone morphogenic protein-4
D. Bone morphogenic protein-7
E. Bone morphogenic protein-3